Nitric oxide synthase inhibitors protect against rotenone-induced, oxidative stress mediated parkinsonism in rats

Neurochemistry International

Volumn 62, Issue 5, 2013, Pages 674-683

  Madathil, K S ^a   Karuppagounder, S S ^a   Haobam, R ^a   Varghese, M ^a   Rajamma, U ^b   Mohanakumar, K P ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Manovikas Biomedical Research and Diagnostic Centre 482   (India)

Author keywords

Behavioral recovery; Hydroxyl radicals; NADPH diaphorase; Neuroprotection; Nitric oxide; Nitric oxide synthase inhibition

Indexed keywords

7 NITROINDAZOLE; AMPHETAMINE; APOMORPHINE; CATALASE; DOPAMINE; GLUTATHIONE; HYDROXYL RADICAL; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; ROTENONE; SUPEROXIDE DISMUTASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIOXIDANTS; BASE SEQUENCE; DNA PRIMERS; DOPAMINE; ENZYME INHIBITORS; MALE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROTENONE;

ANIMALIA; RATTUS; RODENTIA;

EID: 84875691527     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.01.007     Document Type: Article

References (74)

1. A.A. Abdin, and N.I. Sarhan Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity Neurosci. Res. 71 2011 387 395
2. M. Alam, and W.J. Schmidt Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats Behav. Brain Res. 136 2002 317 324
3. A. Almeida, S.J. Heales, J.P. Bolanos, and J.M. Medina Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion Brain Res. 790 1998 209 216
4. K. Aquilano, S. Baldelli, G. Rotilio, and M.R. Ciriolo Role of nitric oxide synthases in Parkinson's disease: a review on the antioxidant and anti-inflammatory activity of polyphenols Neurochem. Res. 33 2008 2416 2426
5. A. Bal-Price, and G.C. Brown Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity J. Neurosci. 21 2001 6480 6491
6. M.K. Barthwal, N. Srivastava, and M. Dikshit Role of nitric oxide in a progressive neurodegeneration model of Parkinson's disease in the rat Redox. Rep. 6 2001 297 302
7. V. Bashkatova, M. Alam, A. Vanin, and W.J. Schmidt Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain Exp. Neurol. 186 2004 235 241
8. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
9. G.C. Brown Nitric oxide and neuronal death Nitric oxide 23 2010 153 165
10. G.C. Brown, and A. Bal-Price Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria Mol. Neurobiol. 27 2003 325 355
11. G.C. Brown, and C.E. Cooper Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase FEBS Lett. 356 1994 295 298
12. S. Canals, M.J. Casarejos, S. de Bernardo, E. Rodriguez-Martin, and M.A. Mena Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease J. Neurochem. 79 2001 1183 1195
13. Q. Cao, L.R. Wei, L.L. Lu, C.L. Zhao, H.Y. Zhao, and H. Yang Astrocytes protect MN9D neuronal cells against rotenone-inducedoxidative stress by a glutathione-dependent mechanism Sheng Li Xue Bao 25 59 2007 253 259
14. K. Castagnoli, S. Palmer, A. Anderson, T. Bueters, and N. Castagnoli Jr. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Chem. Res. Toxicol. 10 1997 364 368
15. Y.C. Chung, S.R. Kim, J.Y. Park, E.S. Chung, K.W. Park, S.Y. Won, E. Bok, M. Jin, E.S. Park, S.H. Yoon, H.W. Ko, Y.S. Kim, and B.K. Jin Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation Neuropharmacology 60 2011 963 974
16. S.J. Chinta, and J.K. Andersen Reversible inhibition of mitochondrialcomplex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease Free Radic. Biol. Med. 41 2006 1442 1448
17. P. Chomczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162 1987 156 159
18. A.P. Chou, S. Li, A.G. Fitzmaurice, and J.M. Bronstein Mechanisms of rotenone-induced proteasome inhibition Neurotoxicology 31 2010 367 372
19. G.L. Chu, Y. Xin, J. Cheng, and S.Y. Bi Expression of neuronal nitric oxide synthase in brain tissue of hypoxic-ischemic neonatal rat and the cerebral protective effect of neuronal nitric oxide synthase inhibitor 7-nitroindazole Zhonghua Yi Xue Za Zhi 84 2004 156 158
20. E. Clementi, G.C. Brown, M. Feelisch, and S. Moncada Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione Proc. Natl. Acad. Sci. USA 95 1998 7631 7636
21. B.P. Connop, R.J. Boegman, R.J. Beninger, and K. Jhamandas Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase Neuropharmacology 35 1996 459 465
22. V.L. Dawson, V.M. Kizushi, P.L. Huang, S.H. Snyder, and T.M. Dawson Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice J. Neurosci. 16 1996 2479 2487
23. D.A. Di Monte, J.E. Royland, A. Anderson, K. Castagnoli, N. Castagnoli Jr., and J.W. Langston Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity J. Neurochem. 69 1997 1771 1773
24. D.J. Eve, A.P. Nisbet, A.E. Kingsbury, E.L. Hewson, S.E. Daniel, A.J. Lees, C.D. Marsden, and O.J. Foster Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease Brain Res. Mol. Brain Res. 63 1998 62 71
25. A.I. Ferger, L. Campanelli, K.N. Reimer, K.N. Muth, I. Merdian, A.C. Ludolph, and A. Witting Effects of mitochondrial dysfunction on the immunological properties of microglia J. Neuroinflammation 11 7 2010 45
26. G. Filomeni, I. Graziani, D. De Zio, L. Dini, D. Centonze, G. Rotilio, and M.R. Ciriolo Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease Neurobiol. Aging 33 2012 767 785
27. S.M. Fleming, C. Zhu, P.O. Fernagut, A. Mehta, C.D. DiCarlo, R.L. Seaman, and M.F. Chesselet Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone Exp. Neurol. 187 2004 418 429
28. H.M. Gao, H. Zhou, F. Zhang, B.C. Wilson, W. Kam, and J.S. Hong HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration J Neurosci. 31 2011 1081 1092
29. K. Gołembiowska, and A. Dziubina The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2 Neurotox. Res. 22 2012 150 157
30. + neurotoxicity in cerebellar granule cells by antioxidants Cell Biol. Int. 28 2004 373 380
31. T.N. Grammatopoulos, F. Ahmadi, S.M. Jones, M.W. Fariss, J.A. Weyhenmeyer, and W.M. Zawada Angiotensin II protects cultured midbrain dopaminergic neurons against rotenone-induced cell death Brain Res. 1045 2005 64 71
32. J. Han, F.C. Cheng, Z. Yang, and G. Dryhurst Inhibitors of mitochondrial respiration, iron (II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: potential implications to Parkinson's disease J. Neurochem. 73 1999 1683 1695
33. P. Hantraye, E. Brouillet, R. Ferrante, S. Palfi, R. Dolan, R.T. Matthews, and M.F. Beal Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons Nat. Med. 2 1996 1017 1021
34. Y. He, S.Z. Imam, Z. Dong, J. Jankovic, S.F. Ali, S.H. Appel, and W. Le Role of nitric oxide in rotenone-induced nigro-striatal injury J. Neurochem. 86 2003 1338 1345
35. T. Herraiz, V.J. Arán, and H. Guillén Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO) Free Radic. Res. 43 2008 975 984
36. B.T. Hope, G.J. Michael, K.M. Knigge, and S.R. Vincent Neuronal NADPH diaphorase is a nitric oxide synthase Proc. Natl. Acad. Sci. USA 88 1991 2811 2814
37. M. Inden, Y. Kitamura, A. Tamaki, T. Yanagida, T. Shibaike, A. Yamamoto, K. Takata, H. Yasui, T. Taira, H. Ariga, and T. Taniguchi Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice Neurochem. Int. 55 2009 760 767
38. H. Jia, Z. Liu, X. Li, Z. Feng, J. Hao, X. Li, W. Shen, H. Zhang, and J. Liu Synergistic anti-Parkinsonism activity of high doses of B vitamins in a chronic cellular model Neurobiol. Aging 31 2010 636 646
39. A. Jara-Prado, A. Ortega-Vazquez, L. Martinez-Ruano, C. Rios, and A. Santamaria Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition Neurotox. Res. 5 2003 237 243
40. H. Kaur, S. Chauhan, and R. Sandhir Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease Neurochem. Res. 36 2011 1435 1443
41. Karuppagounder, S.S., Madathil, K.S., Pandey, M., Haobam, R., Usha, R., Mohanakumar, K.P., 2013. Quercetin up-regulates mitochondrial complex-I activity to protect against oxidative stress-mediated apoptotic cell death of dopaminergic neurons. Neuroscience http://dx.doi.org/10.1016/j.neuroscience. 2013.01.032.
42. N. Li, K. Ragheb, G. Lawler, J. Sturgis, B. Rajwa, J.A. Melendez, and J.P. Robinson Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production J. Biol. Chem. 278 2003 8516 8525
43. G.T. Liberatore, V. Jackson-Lewis, S. Vukosavic, A.S. Mandir, M. Vila, W.G. McAuliffe, V.L. Dawson, T.M. Dawson, and S. Przedborski Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease Nat. Med. 5 1999 1403 1409
44. C.H. Lin, J.Y. Huang, C.H. Ching, and J.I. Chuang Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-inducedparkinsonian rats J. Pineal Res. 44 2008 205 213
45. A.K. Loihl, and S. Murphy Expression of nitric oxide synthase-2 in glia associated with CNS pathology Prog. Brain Res. 118 1998 253 267
46. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with a Folin phenol reagent J. Biol. Chem. 193 1951 265 275
47. G.M. Mackenzie, M.J. Jackson, P. Jenner, and C.D. Marsden Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset Synapse 26 1997 301 316
48. Madathil, K.S., Saravanan, K.S., Mohanakumar, K.P., 2013. Sodium salicylate protects against rotenone-induced parkinsonism in rats. Synapse (under revision).
49. K.P. Mohanakumar, I. Hanbauer, and C.C. Chiueh Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity J. Chem. Neuroanat. 14 1998 195 205
50. D. Muralikrishnan, and K.P. Mohanakumar Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice FASEB J. 12 1998 905 912
51. E. Rodriguez-Martin, M.J. Casarejos, S. Canals, S. de Bernardo, and M.A. Mena Thiolic antioxidants protect from nitric oxide-induced toxicity in fetal midbrain cultures Neuropharmacology 43 2002 877 888
52. J.E. Royland, K. Delfani, J.W. Langston, A.M. Janson, and D.A. Di Monte 7-Nitroindazole prevents 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced ATP loss in the mouse striatum Brain Res. 839 1999 41 48
53. S. Samantaray, V.H. Knaryan, C. Le Gal, S.K. Ray, and N.L. Banik Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rotenone Neuroscience 192 2011 263 274
54. K.S. Saravanan, K.M. Sindhu, and K.P. Mohanakumar Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease Brain. Res. 1049 2005 147 155
55. K.S. Saravanan, K.M. Sindhu, K.S. Senthilkumar, and K.P. Mohanakumar l-Deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats Neurochem. Int. 49 2006 28 40
56. K.S. Saravanan, K.M. Sindhu, and K.P. Mohanakumar Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model J. Pineal Res. 42 2007 247 253
57. F. Schopfer, N. Riobo, M.C. Carreras, B. Alvarez, R. Radi, A. Boveris, E. Cadenas, and J.J. Poderoso Oxidation of ubiquinol by peroxynitrite: implications for protection of mitochondria against nitrosative damage Biochem. J. 349 2000 35 42
58. T.A. Seaton, J.M. Cooper, and A.H. Schapira Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors Brain Res. 777 1997 110 118
59. S.B. Shaikh, and L.F. Nicholson Effects of chronic low dose rotenone treatment on human microglial cells Mol. Neurodegener. 31 4 2009 55
60. K.M. Sindhu, K.S. Saravanan, and K.P. Mohanakumar Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion Brain Res. 1051 2005 25 34
61. K.M. Sindhu, R. Banerjee, K.S. Senthilkumar, K.S. Saravanan, B. China Raju, J. Madhusudan Rao, and K.P. Mohanakumar Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine Pharmacol. Biochem. Behav. 84 2006 321 329
62. I. Sipos, L. Tretter, and V. Adam-Vizi Quantitative relationship between inhibition of respiratory complexes and formation of reactive oxygen species in isolated nerve terminals J. Neurochem. 84 2003 112 118
63. T.S. Smith, and J.P. Bennett Jr. Mitochondrial toxins in models of neurodegenerative diseases. I: in vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions Brain Res. 765 1997 183 188
64. L. Sun, L. Gu, S. Wang, J. Yuan, H. Yang, J. Zhu, and H. Zhang N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity PLoSOne 7 2012 e32503
65. R. Verma, and B. Nehru Effect of centrophenoxine against rotenone-inducedoxidative stress in an animal model of Parkinson's disease Neurochem. Int. 55 2009 369 375
66. 2+-induced permeabilization promotes free radical release from rat brain mitochondria with partially inhibited complex I J. Neurochem. 93 2005 526 537
67. M. Watabe, and T. Nakaki Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells Mol. Pharmacol. 74 2008 933 940
68. H. Watanabe, Y. Muramatsu, R. Kurosaki, M. Michimata, M. Matsubara, Y. Imai, and T. Araki Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study Eur. Neuropsychopharmacol. 14 2004 93 104
69. Y. Watanabe, H. Kato, and T. Araki Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease Metab. Brain Dis. 23 2008 51 69
70. D.C. Wu, V. Jackson-Lewis, M. Vila, K. Tieu, V. Teismann, C. Vadseth, D.K. Choi, H. Ischiropoulos, and S. Przedborski Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson disease J. Neurosci. 22 2002 1763 1771
71. N. Xiong, J. Huang, C. Chen, Y. Zhao, Z. Zhang, M. Jia, Z. Zhang, L. Hou, H. Yang, X. Cao, Z. Liang, Y. Zhang, S. Sun, Z. Lin, and T. Wang Dl-3-n-Butylphthalide, a natural antioxidant, protects dopamine neurons in rotenone models for Parkinson's disease Neurobiol. Aging 33 2012 1777 1791
72. S.A. Zaitone, D.M. Abo-Elmatty, and A.A. Shaalan Acetyl-l-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy Pharmacol. Biochem. Behav. 100 2012 347 360
73. H. Zhang, H. Jia, J. Liu, N. Ao, B. Yan, W. Shen, X. Wang, X. Li, C. Luo, and J. Liu Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease J. Cell. Mol. Med. 14 2010 215 225
74. H. Zhou, F. Zhang, S.H. Chen, D. Zhang, B. Wilson, J.S. Hong, and H.M. Gao Rotenone activates phagocyte NADPH oxidase by binding to its membrane subunit gp91phox Free Radic. Biol. Med. 52 2012 303 313